Click on the image to see the entire picture

Makoto™ Intravascular Imaging System

Unique IVUS/NIRS Dual source imaging system.


Brochure Technical specification Would you talk with us? Click here and fill the form.
  • Click on the image to see the entire picture

    “Now FDA indicated to identify patients and plaques at increased risk of major adverse cardiovascular events (MACE).”


    Makoto™ Imaging System

    Makoto™ is a dual-modality intravascular imaging device with the ability to assess vessel structure and plaque composition via IVUS imaging and near infrared spectroscopy (NIRS) Lipid Core Plaque detection technologies.

    New platform designed to improve morphological evaluation of plaque.

    Broadband (35 MHz -65 MHz extended bandwidth) for high-resolution images even in the deepest layers of the vessel, greatly improving the experience of an IVUS rating.

    The intuitive interface, flexible workflow and easy

    The only FDA-cleared dual modality intravascular imaging device on the market capable of detecting both plaque structure and composition.

    The Makoto Imaging System is accompanied by the Dualpro catheter – the only dual-sensor catheter on the market utilizing:

    IVUS  for plaque structure visualization. The only extended bandwidth catheter offering crisper image and greater depth of field than any other IVUS catheter on the market.

    NIRS for plaque composition analysis. The only catheter FDA-indicated to detect Lipid Core Plaque (LCP) offering clinicians the ability to distinguish at a glance between stable calcified plaque and unstable LCP.

    Unique chemogram display shows locations of lipid core plaque in the vessel, and quantifies lipid core with Lipid Core Burden Index (LCBI).

    • Clinicians confidence in decision-making
    • Procedure will be done based on more complete set of data thoughtout real-time vessel structure & composition visualization
    • Better stent placement
    • Reduced risks of complications
    • Drug therapy adjustments
    • Better procedural outcomes
    • Better imaging for same cost
    • Improved procedure outcomes
    • Reduced cost of complications

New interview on theme of VULNERABLE PATIENT.

Today dr Luigi di Serafino of University Federico II in…

Read More >

15 minutes with... - Interview to prof. Paolo Calabrò

The VULNERABLE PATIENT WHO is the vulnerable patient ? HOW…

Read More >


The PROSPECT II study was presented as Late-Breaking Clinical Trials…

Read More >


For read click on The PROSPECT ABSORB Study (Jacc 2020)

Read More >

NIRS-IVUS for decision making in ACS

How can influence NIRS-IVUS of interventional cardiologists daily?

Read More >


Infraredx, a Nipro company, is advancing the diagnosis and management…

Read More >

Cardiovascular Imaging

Cardiovascular imaging techniques has enlarged the diagnostic capabilities for any…

Read More >

You could be interested also to......

QFR (Quantitative Flow Ratio)

QFR, powered by QAngio XA 3D  is a novel approach for fast and accurate functional…

TruePhysio™ & VivoCardio™ System

TruePhysio™ “Rapid. Accurate. Reliable. Cost-effective”   Rapid exchange FFR microcatheter, TruePhysio™ is the only alternative…


It is a software processing medical image for cardiac CT cases It extracts coronary tree…


Software processing medical image for cardiac CMR cases


Ultra-thin DES of 4° generation with 60μm strut thickness across all diameters.  

For further information fill the form below